Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories reports second-quarter growth and elevates its full-year earnings forecast following strong performance across multiple sectors.
Coverage (9)
- Abbott's Q2 2026 earnings call: What drove results and what should investors watch next? Abbott · 45d ago
- ABT: Q2 sales up 4.8%, EPS beats, guidance raised; strong growth in nutrition, diagnostics, and devices TradingView · 45d ago
- Abbott raises 2026 profit forecast on strength in diagnostics, medical devices Reuters · 45d ago
- Abbott Laboratories (NYSE:ABT) Surprises With Q2 CY2026 Sales Yahoo Finance · 45d ago
- Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise Bloomberg.com · 45d ago
- Abbott posted stronger-than-expected profit and is raising its full-year earnings outlook qz.com · 45d ago
- Why Abbott Earnings Are Sending the Stock Higher Barron's · 45d ago
- Abbott Laboratories Sales Rise on Diagnostics Growth WSJ · 45d ago
- Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance Abbott MediaRoom · 45d ago
Where it stands
Abbott Laboratories reported a 4.8% increase in sales for the second quarter of 2026. The company concurrently raised its full-year earnings per share (EPS) guidance following the financial results.
Coverage from Reuters, Bloomberg, The Wall Street Journal, and Barron's highlights growth across the company’s nutrition, diagnostics, and medical devices divisions. Financial news outlets including TradingView and Yahoo Finance note that the reported figures surpassed analyst expectations.
Market observers are monitoring how sustained growth in the diagnostics and medical device sectors will influence the updated profit trajectory through the remainder of the year. Coverage does not yet specify the exact dollar amount of the revised full-year EPS guidance.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 45d ago.
Answered
What caused the increase in Abbott's sales?
Sales growth was driven by performance in the company's nutrition, diagnostics, and medical devices divisions.
Did Abbott adjust its financial outlook?
Yes, Abbott raised its full-year earnings per share guidance.
How did the second-quarter sales compare to expectations?
The second-quarter sales and profit figures were stronger than expected.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Reddit shares sink 7% on 'choppy' search referrals even as results blow past estimates
Reddit shares dropped 7% in late trading despite the company reporting 61% sales growth for the second quarter of 2026.
Microsoft's stock rockets more than 15% for largest single-day jump in history
Microsoft shares climbed over 15% yesterday, marking the largest single-day market capitalization gain in the company's history.
Amazon Stock: Q2 Earnings Could Highlight 'Prescient' AI Approach
Investors and market analysts are centering on Amazon's upcoming Q2 earnings, with focus split between the company's AI strategy and cloud growth.
Microsoft Corp (MSFT) (Q4 2026) Earnings Call Highlights: Record Revenue Surpasses $331 ...
Microsoft reports record quarterly revenue exceeding $331 billion, driven by surging Azure growth and AI-focused investment strategies.
Robinhood Earnings Soar Above Views On Record Trading Volumes
Robinhood shares slid 4% despite the company posting record quarterly revenue and profits that surpassed market expectations.
Scientists Can Now Spot Alzheimer’s 10 Years Before Symptoms
Diagnostic advancements in blood-based testing are shifting the Alzheimer's detection timeline, enabling the identification of risks years before symptoms.